share_log

新天药业:董事会关于本次交易符合《上市公司监管指引第9号——上市公司筹划和实施重大资产重组的监管要求》第四条规定的说明

Xintian Pharmaceutical: Explanation of the Board of Directors that this transaction complies with the provisions of Article 4 of the “Supervisory Guidelines for Listed Companies No. 9 - Regulatory Requirements for Listed Companies to Plan and Implement Maj

深证信a股 ·  Mar 7
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more